Skip to main
BLCO

BLCO Stock Forecast & Price Target

BLCO Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 23%
Buy 31%
Hold 46%
Sell 0%
Strong Sell 0%

Bulls say

Bausch & Lomb is a strong player in the vision care industry, with a diverse portfolio of products and a positive sales and earnings momentum. Their entry into the premium contact lens market and upcoming launch of Beyond EDOF are expected to drive revenue and margin growth. The company's focus on research and innovation, along with its strong presence in the under-served dry eye market, position it well for future success. Their growth in key segments, including IOLs and pharmaceuticals, supports an optimistic outlook for the company's EBITDA margins.

Bears say

Bausch & Lomb is facing potential headwinds in its vision care and surgical segments, with the potential for underperforming sales and weakening consumer demand. While the company has a diverse portfolio of eye care products, its premium intraocular lenses have shown promising signs of growth, but any slowdown in this area could impact the company's overall margins. Additionally, the company's next-generation contact lens innovation pipeline may also face challenges and could impact growth expectations.

BLCO has been analyzed by 13 analysts, with a consensus rating of Buy. 23% of analysts recommend a Strong Buy, 31% recommend Buy, 46% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Bausch + Lomb Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Bausch + Lomb Corp (BLCO) Forecast

Analysts have given BLCO a Buy based on their latest research and market trends.

According to 13 analysts, BLCO has a Buy consensus rating as of Sep 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $19.31, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $19.31, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Bausch + Lomb Corp (BLCO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.